Apple Chemie's 30%+ Growth Test: Can Indigo Sustain 25% Consolidated Expansion?
Indigo Paints enters Q1 FY27 riding a strong finish to FY26, with new paint capacity coming online and Apple Chemie driving the consolidated growth story. But standalone decorative paint growth stalled in Q3, and the Street is watching closely whether the subsidiary can offset flat demand in core paints.
What to Expect
~₹360 Cr
On-plan for 25% FY27 growth guidance; Q1 FY26 was ₹286 Cr (est.)
~₹250–260 Cr
Growth stalled in Q3 (+3% YoY); Street watching for turnaround or further decel.
>30% YoY
Critical to hit 25% consolidated target; delivered 31.6% in prior quarters.
15–18%
Q4 FY26 was elevated at 18.5%; margin compression expected as raw-material cost relief fades.
A strong print vs weak: A strong Q1 print = consolidated revenue tracking ₹360+ Cr with Apple Chemie sustaining 30%+ growth, standalone stabilizing at flat or modest growth, and EBITDA margin above 17%. A weak print = standalone flat or declining, Apple Chemie growth below 25%, and margins compressing below 15% as pricing pressure from JSW Paints and Birla Opus's new capacity builds. Either outcome will hinge on whether the new water-based and solvent-based paint plants, now online, drive traction in premium segments.
On Track?
Indigo Paints is delivering on its FY26 trajectory: Q4 FY26 revenue reached ₹398 Cr (+17.5% QoQ), with net profit jumping 56% QoQ to ₹56.4 Cr, and operating margins expanding to 22.8% from 14.8% in Q1. Full-year FY26 net profit of ₹144.4 Cr shows accelerating profitability. The company's 25% consolidated revenue growth target for FY27 is dependent on Apple Chemie maintaining 30%+ growth and the standalone decorative paint business picking up from Q3's flat +3% YoY. New capacity expansion (water-based plant at 90,000 KLPA, operational June 2026) signals management confidence in demand, but execution risk is high given industry volume growth halving to 4–5% YoY amid competition.
Since Last Quarter
Capacity & Expansion: Water-based paint plant (90,000 KLPA capacity) now operational from June 2026; solvent-based plant (12,000 KLPA) started in Feb 2026. Both are ahead of schedule, enabling new product launches and market share gains in premium segments. Capital Allocation: Final dividend of ₹5.00 per share (50% payout ratio) approved for FY26, reflecting management confidence in earnings run-rate. Incentives: 44,400 ESOP grants approved in May 2026 at ₹10 exercise price, signaling mid-to-large growth expectations. Regulatory: GST-related notices (₹3.86 Cr + ₹19.26 Cr) remain under appeal; not material to near-term trajectory.
1 · Can Standalone Paint Growth Reignite?
Q3 FY26 showed only +3% YoY growth in standalone revenues (₹297 Cr). Q1 FY27 must show acceleration to at least 8–10% YoY to restore confidence. Flat or negative print signals market share loss to JSW/Birla and would pressure guidance.
2 · Apple Chemie: Can It Sustain 30%+ Growth?
Construction chemicals delivered 31.6% YoY growth in prior quarters. Q1 result will show if momentum persists or deceleration has begun. Below 25% growth would be a miss vs. management's 30%+ consolidated target and would force multiple compression.
3 · Margin & Pricing Power in a Competitive Market
Q4 FY26 EBITDA margin of 18.5% was elevated (Q1–Q3 averaged ~15.8%). Analysts will gauge Q1 FY27 margins as raw-material cost relief fades and competitive discounting pressures pricing. Hold above 17% = strength; below 15% = concerning.
Indigo Paints enters Q1 FY27 on the back of a strong FY26 finish, with new paint capacity online and Apple Chemie driving the consolidated growth narrative. But the Street is divided: bulls see a construction chemicals growth story offsetting soft decorative paint demand; bears see an over-valued story dependent on one subsidiary, with standalone paint stagnating and competitive threats rising. The 25% consolidated growth guidance is the threshold — beat it, and the stock re-rates; miss it, and the 30–32x P/E multiple compresses sharply. Watch standalone paint growth, Apple Chemie's momentum, and management's tone on FY27 guidance during the earnings call.
Indigo Paints Q1 FY27: consol PAT +60% YoY to ₹41.7 Cr, margins expand despite RM pressure
PAT +60.03% YoY · revenue +19.69% · margins expanding · beat vs street
₹369.67 Cr
+19.69% YoY
₹41.7 Cr
+60.03% YoY
10.98%
+2.7pp YoY
₹8.76
Indigo Paints' consolidated PAT (primary basis) rose 60.0% YoY to ₹41.7 Cr on revenue of ₹369.7 Cr, up 19.7% YoY — standalone tracked closely at ₹42.4 Cr PAT (+60.7% YoY) on ₹350.0 Cr revenue (+18.7% YoY). Both reported figures are clean YoY comparisons since neither this quarter nor the year-ago quarter carried any exceptional item (the ₹6.13 Cr consolidated labour-code charge flagged in the notes was a FY26 full-year balancing entry only, not a quarterly one). Sequentially, revenue fell 13.1% and PAT fell 29.5% versus Q4 FY26, which is a seasonal step-down for a paints business coming off its strongest quarter, not underlying deterioration.
Q1 FY-2027 vs prior quarters
The margin story is bifurcated by basis. Standalone EBITDA margin expanded ~290bps YoY to 17.7% (from 14.8%) on a gross margin held at 45.3% despite supply-chain disruptions, per the company's press release. Consolidated EBITDA margin (excluding other income) also expanded YoY to 16.8% from 14.35%, but eased sharply from 22.47% in Q4 FY26 — management attributes this to rising raw-material costs and inventory buildup at the group level. Consolidated NPM expanded to 11.0% from 8.28% YoY, flattered by a jump in other income to ₹10.2 Cr (from ₹6.0 Cr YoY), which the company describes as mark-to-market treasury gains — a non-operating tailwind investors should separate from the operating margin story.
The stock went into the print at ₹1,121, up 3.4% over the past month of trading.
What the summary numbers don't show
Basic EPS ₹8.76 consol (₹5.44 YoY), ₹8.89 standalone (₹5.53 YoY) — sequential decline from Q4 FY26's ₹12.10/₹12.03 reflects a seasonally stronger Q4
Management has signaled a more aggressive stance on top-line growth for FY27, aiming to outpace industry growth by pursuing market share gains. This strategy may involve a deliberate trade-off in gross margins (potentially 200-250 bps reduction) to fund increased spending on trade schemes and influencer engagement. Whi
— This quarter: beat
Against our pre-result preview, the print clears the bar on every watch item: standalone revenue growth of 18.7% resolves the "can standalone paint growth reignite" question raised after a stalled Q3, printing well above the ~₹250-260 Cr expectation; Apple Chemie sustained 40.1% growth against a >30% FY27 target and the preview's expected consol revenue of ~₹360 Cr; and EBITDA margins (16.8% consol / 17.7% standalone) landed at or above the previewed 15-18% range. Against management's own May 2026 guidance — an aggressive FY27 top-line push funded by a flagged 200-250bps gross-margin trade-off, with EBITDA margins expected merely stable — the quarter beats: margins expanded rather than compressed, and growth came in strong on both bases without visible erosion in gross margin.
W1
Consol EBITDA margin fell to 16.8% from 22.47% QoQ on RM cost inflation and inventory buildup — watch if Q2 FY27 margin stabilizes as management's guided industry price hikes offset RM costs
W2
Apple Chemie grew 40.1% this quarter against a >30% FY27 target — watch whether this pace holds through the rest of FY27
W3
Standalone gross margin held at 45.3% this quarter versus management's flagged 200-250bps FY27 trade-off risk — watch if margin gives way as trade-scheme/influencer spend ramps